Stojkovic, Marija Mostarica

Link to this page

Authority KeyName Variants
9120b671-3636-48e9-8594-2c352add6c42
  • Stojkovic, Marija Mostarica (4)
Projects
No records found.

Author's Bibliography

A Comparative Analysis of Multiple Sclerosis-Relevant Anti-Inflammatory Properties of Ethyl Pyruvate and Dimethyl Fumarate

Miljković, Đorđe; Blaževski, Jana; Petković, Filip; Nikolovski, Neda; Momčilović, Miljana; Stanisavljević, Suzana; Jevtić, Bojan; Stojkovic, Marija Mostarica; Spasojevic, Ivan

(2015)

TY  - JOUR
AU  - Miljković, Đorđe
AU  - Blaževski, Jana
AU  - Petković, Filip
AU  - Nikolovski, Neda
AU  - Momčilović, Miljana
AU  - Stanisavljević, Suzana
AU  - Jevtić, Bojan
AU  - Stojkovic, Marija Mostarica
AU  - Spasojevic, Ivan
PY  - 2015
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/1987
AB  - Dimethyl fumarate (DMF), a new drug for multiple sclerosis (MS)
   treatment, acts against neuroinflammation via mechanisms that are
   triggered by adduct formation with thiol redox switches. Ethyl pyruvate
   (EP), an off-the-shelf agent, appears to be a redox analog of DMF, but
   its immunomodulatory properties have not been put into the context of MS
   therapy. In this article, we examined and compared the effects of EP and
   DMF on MS-relevant activity/functions of T cells, macrophages,
   microglia, and astrocytes. EP efficiently suppressed the release of MS
   signature cytokines, IFN-gamma and IL-17, from human PBMCs. Furthermore,
   the production of these cytokines was notably decreased in
   encephalitogenic T cells after in vivo application of EP to rats.
   Production of two other proinflammatory cytokines, IL-6 and TNF, and NO
   was suppressed by EP in macrophages and microglia. Reactive oxygen
   species production in macrophages, microglia activation, and the
   development of Ag-presenting phenotype in microglia and macrophages were
   constrained by EP. The release of IL-6 was reduced in astrocytes.
   Finally, EP inhibited the activation of transcription factor NF-kappa B
   in microglia and astrocytes. Most of these effects were also found for
   DMF, implying that EP and DMF share common targets and mechanisms of
   action. Importantly, EP had in vivo impact on experimental autoimmune
   encephalomyelitis, an animal model of MS. Treatment with EP resulted in
   delay and shortening of the first relapse, and lower clinical scores,
   whereas the second attack was annihilated. Further studies on the
   possibility to use EP as an MS therapeutic are warranted.
T2  - Journal of Immunology
T1  - A Comparative Analysis of Multiple Sclerosis-Relevant Anti-Inflammatory
 Properties of Ethyl Pyruvate and Dimethyl Fumarate
IS  - 6
VL  - 194
DO  - 10.4049/jimmunol.1402302
SP  - 2493
EP  - 2503
ER  - 
@article{
author = "Miljković, Đorđe and Blaževski, Jana and Petković, Filip and Nikolovski, Neda and Momčilović, Miljana and Stanisavljević, Suzana and Jevtić, Bojan and Stojkovic, Marija Mostarica and Spasojevic, Ivan",
year = "2015",
abstract = "Dimethyl fumarate (DMF), a new drug for multiple sclerosis (MS)
   treatment, acts against neuroinflammation via mechanisms that are
   triggered by adduct formation with thiol redox switches. Ethyl pyruvate
   (EP), an off-the-shelf agent, appears to be a redox analog of DMF, but
   its immunomodulatory properties have not been put into the context of MS
   therapy. In this article, we examined and compared the effects of EP and
   DMF on MS-relevant activity/functions of T cells, macrophages,
   microglia, and astrocytes. EP efficiently suppressed the release of MS
   signature cytokines, IFN-gamma and IL-17, from human PBMCs. Furthermore,
   the production of these cytokines was notably decreased in
   encephalitogenic T cells after in vivo application of EP to rats.
   Production of two other proinflammatory cytokines, IL-6 and TNF, and NO
   was suppressed by EP in macrophages and microglia. Reactive oxygen
   species production in macrophages, microglia activation, and the
   development of Ag-presenting phenotype in microglia and macrophages were
   constrained by EP. The release of IL-6 was reduced in astrocytes.
   Finally, EP inhibited the activation of transcription factor NF-kappa B
   in microglia and astrocytes. Most of these effects were also found for
   DMF, implying that EP and DMF share common targets and mechanisms of
   action. Importantly, EP had in vivo impact on experimental autoimmune
   encephalomyelitis, an animal model of MS. Treatment with EP resulted in
   delay and shortening of the first relapse, and lower clinical scores,
   whereas the second attack was annihilated. Further studies on the
   possibility to use EP as an MS therapeutic are warranted.",
journal = "Journal of Immunology",
title = "A Comparative Analysis of Multiple Sclerosis-Relevant Anti-Inflammatory
 Properties of Ethyl Pyruvate and Dimethyl Fumarate",
number = "6",
volume = "194",
doi = "10.4049/jimmunol.1402302",
pages = "2493-2503"
}
Miljković, Đ., Blaževski, J., Petković, F., Nikolovski, N., Momčilović, M., Stanisavljević, S., Jevtić, B., Stojkovic, M. M.,& Spasojevic, I.. (2015). A Comparative Analysis of Multiple Sclerosis-Relevant Anti-Inflammatory
 Properties of Ethyl Pyruvate and Dimethyl Fumarate. in Journal of Immunology, 194(6), 2493-2503.
https://doi.org/10.4049/jimmunol.1402302
Miljković Đ, Blaževski J, Petković F, Nikolovski N, Momčilović M, Stanisavljević S, Jevtić B, Stojkovic MM, Spasojevic I. A Comparative Analysis of Multiple Sclerosis-Relevant Anti-Inflammatory
 Properties of Ethyl Pyruvate and Dimethyl Fumarate. in Journal of Immunology. 2015;194(6):2493-2503.
doi:10.4049/jimmunol.1402302 .
Miljković, Đorđe, Blaževski, Jana, Petković, Filip, Nikolovski, Neda, Momčilović, Miljana, Stanisavljević, Suzana, Jevtić, Bojan, Stojkovic, Marija Mostarica, Spasojevic, Ivan, "A Comparative Analysis of Multiple Sclerosis-Relevant Anti-Inflammatory
 Properties of Ethyl Pyruvate and Dimethyl Fumarate" in Journal of Immunology, 194, no. 6 (2015):2493-2503,
https://doi.org/10.4049/jimmunol.1402302 . .
14
33
25
34

Tumor necrosis factor stimulates expression of CXCL12 in astrocytes

Blaževski, Jana; Petković, Filip; Momčilović, Miljana; Jevtić, Bojan; Stojkovic, Marija Mostarica; Miljković, Đorđe

(2015)

TY  - JOUR
AU  - Blaževski, Jana
AU  - Petković, Filip
AU  - Momčilović, Miljana
AU  - Jevtić, Bojan
AU  - Stojkovic, Marija Mostarica
AU  - Miljković, Đorđe
PY  - 2015
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/1937
AB  - It has been increasingly appreciated that tumor necrosis factor (TNF)
   performs various protective and anti-inflammatory functions in multiple
   sclerosis (MS) and its animal model experimental autoimmune
   encephalomyelitis (EAE). Recently, CXCL12 has been identified as a key
   inhibitor of leukocyte entry into the central nervous system (CNS) and
   as a regulator of inflammation resulting from the invasion. Here, a
   positive correlation between expression of TNF and CXCL12 in the CNS
   samples of EAE rats is presented. Also, it is shown that TNF potentiates
   CXCL12 expression in astrocytes. These results contribute to a view that
   TNF produced within the CNS plays a protective role in
   neuroinflammation. (C) 2015 Elsevier GmbH. All rights reserved.
T2  - Immunobiology
T1  - Tumor necrosis factor stimulates expression of CXCL12 in astrocytes
IS  - 7
VL  - 220
DO  - 10.1016/j.imbio.2015.01.007
SP  - 845
EP  - 850
ER  - 
@article{
author = "Blaževski, Jana and Petković, Filip and Momčilović, Miljana and Jevtić, Bojan and Stojkovic, Marija Mostarica and Miljković, Đorđe",
year = "2015",
abstract = "It has been increasingly appreciated that tumor necrosis factor (TNF)
   performs various protective and anti-inflammatory functions in multiple
   sclerosis (MS) and its animal model experimental autoimmune
   encephalomyelitis (EAE). Recently, CXCL12 has been identified as a key
   inhibitor of leukocyte entry into the central nervous system (CNS) and
   as a regulator of inflammation resulting from the invasion. Here, a
   positive correlation between expression of TNF and CXCL12 in the CNS
   samples of EAE rats is presented. Also, it is shown that TNF potentiates
   CXCL12 expression in astrocytes. These results contribute to a view that
   TNF produced within the CNS plays a protective role in
   neuroinflammation. (C) 2015 Elsevier GmbH. All rights reserved.",
journal = "Immunobiology",
title = "Tumor necrosis factor stimulates expression of CXCL12 in astrocytes",
number = "7",
volume = "220",
doi = "10.1016/j.imbio.2015.01.007",
pages = "845-850"
}
Blaževski, J., Petković, F., Momčilović, M., Jevtić, B., Stojkovic, M. M.,& Miljković, Đ.. (2015). Tumor necrosis factor stimulates expression of CXCL12 in astrocytes. in Immunobiology, 220(7), 845-850.
https://doi.org/10.1016/j.imbio.2015.01.007
Blaževski J, Petković F, Momčilović M, Jevtić B, Stojkovic MM, Miljković Đ. Tumor necrosis factor stimulates expression of CXCL12 in astrocytes. in Immunobiology. 2015;220(7):845-850.
doi:10.1016/j.imbio.2015.01.007 .
Blaževski, Jana, Petković, Filip, Momčilović, Miljana, Jevtić, Bojan, Stojkovic, Marija Mostarica, Miljković, Đorđe, "Tumor necrosis factor stimulates expression of CXCL12 in astrocytes" in Immunobiology, 220, no. 7 (2015):845-850,
https://doi.org/10.1016/j.imbio.2015.01.007 . .
1
16
12
15

Micro RNA-155 participates in re-activation of encephalitogenic T cells

Jevtić, Bojan; Timotijevic, Gordana; Stanisavljević, Suzana; Momčilović, Miljana; Stojkovic, Marija Mostarica; Miljković, Đorđe

(2015)

TY  - JOUR
AU  - Jevtić, Bojan
AU  - Timotijevic, Gordana
AU  - Stanisavljević, Suzana
AU  - Momčilović, Miljana
AU  - Stojkovic, Marija Mostarica
AU  - Miljković, Đorđe
PY  - 2015
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/1919
AB  - MicroRNAs (miR) are small non-coding RNAs involved in the immune
   response regulation. miR-155 has been attributed a major
   pro-inflammatory role in the pathogenesis of multiple sclerosis and its
   animal model experimental autoimmune encephalomyelitis (EAE). Here, a
   role of miR-155 in re-activation of encephalitogenic CD4(+) T cells was
   investigated. Dark Agouti rats were immunized with myelin basic protein
   (MBP) emulsified in complete Freund's adjuvant. CD4(+) T cells were
   purified from draining lymph node cells (DLNC) obtained in the inductive
   phase and from spinal cord immune cells (SCIC) isolated at the peak of
   EAE. CD4(+) T cells obtained from SCIC (i.e., in vivo re-activated
   cells) had markedly higher expression of miR-155 in comparison to those
   purified from DLNC (not re-activated). Likewise, in vitro re-activation
   of DLNC with MBP led to increase in miR-155 expression. Further, DLNC
   and DLNC CD4(+) T cells were transfected with an inhibitor of miR-155
   during in vitro re-activation. As a result, expression of important
   CD4(+) T cell effector cytokines IFN-gamma and IL-17, but not of
   regulatory cytokines IL-10 and TGF-beta, was reduced. These results
   imply that miR-155 supports re-activation of encephalitogenic CD4+ T
   cells. Our results contribute to a view that miR-155 might be a valuable
   target in multiple sclerosis therapy. (C) 2015 Elsevier Masson SAS. All
   rights reserved.
T2  - Biomedicine & Pharmacotherapy
T1  - Micro RNA-155 participates in re-activation of encephalitogenic T cells
VL  - 74
DO  - 10.1016/j.biopha.2015.08.011
SP  - 206
EP  - 210
ER  - 
@article{
author = "Jevtić, Bojan and Timotijevic, Gordana and Stanisavljević, Suzana and Momčilović, Miljana and Stojkovic, Marija Mostarica and Miljković, Đorđe",
year = "2015",
abstract = "MicroRNAs (miR) are small non-coding RNAs involved in the immune
   response regulation. miR-155 has been attributed a major
   pro-inflammatory role in the pathogenesis of multiple sclerosis and its
   animal model experimental autoimmune encephalomyelitis (EAE). Here, a
   role of miR-155 in re-activation of encephalitogenic CD4(+) T cells was
   investigated. Dark Agouti rats were immunized with myelin basic protein
   (MBP) emulsified in complete Freund's adjuvant. CD4(+) T cells were
   purified from draining lymph node cells (DLNC) obtained in the inductive
   phase and from spinal cord immune cells (SCIC) isolated at the peak of
   EAE. CD4(+) T cells obtained from SCIC (i.e., in vivo re-activated
   cells) had markedly higher expression of miR-155 in comparison to those
   purified from DLNC (not re-activated). Likewise, in vitro re-activation
   of DLNC with MBP led to increase in miR-155 expression. Further, DLNC
   and DLNC CD4(+) T cells were transfected with an inhibitor of miR-155
   during in vitro re-activation. As a result, expression of important
   CD4(+) T cell effector cytokines IFN-gamma and IL-17, but not of
   regulatory cytokines IL-10 and TGF-beta, was reduced. These results
   imply that miR-155 supports re-activation of encephalitogenic CD4+ T
   cells. Our results contribute to a view that miR-155 might be a valuable
   target in multiple sclerosis therapy. (C) 2015 Elsevier Masson SAS. All
   rights reserved.",
journal = "Biomedicine & Pharmacotherapy",
title = "Micro RNA-155 participates in re-activation of encephalitogenic T cells",
volume = "74",
doi = "10.1016/j.biopha.2015.08.011",
pages = "206-210"
}
Jevtić, B., Timotijevic, G., Stanisavljević, S., Momčilović, M., Stojkovic, M. M.,& Miljković, Đ.. (2015). Micro RNA-155 participates in re-activation of encephalitogenic T cells. in Biomedicine & Pharmacotherapy, 74, 206-210.
https://doi.org/10.1016/j.biopha.2015.08.011
Jevtić B, Timotijevic G, Stanisavljević S, Momčilović M, Stojkovic MM, Miljković Đ. Micro RNA-155 participates in re-activation of encephalitogenic T cells. in Biomedicine & Pharmacotherapy. 2015;74:206-210.
doi:10.1016/j.biopha.2015.08.011 .
Jevtić, Bojan, Timotijevic, Gordana, Stanisavljević, Suzana, Momčilović, Miljana, Stojkovic, Marija Mostarica, Miljković, Đorđe, "Micro RNA-155 participates in re-activation of encephalitogenic T cells" in Biomedicine & Pharmacotherapy, 74 (2015):206-210,
https://doi.org/10.1016/j.biopha.2015.08.011 . .
1
10
8
11

Effect of ethyl pyruvate on central nervous system inflammation

Miljković, Đorđe; Petković, Filip; Blaževski, Jana; Momčilović, Miljana; Nikolovski, Neda; Stojkovic, Marija Mostarica; Spasojevic, Ivan

(2014)

TY  - CONF
AU  - Miljković, Đorđe
AU  - Petković, Filip
AU  - Blaževski, Jana
AU  - Momčilović, Miljana
AU  - Nikolovski, Neda
AU  - Stojkovic, Marija Mostarica
AU  - Spasojevic, Ivan
PY  - 2014
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/2138
C3  - Journal of Neuroimmunology
T1  - Effect of ethyl pyruvate on central nervous system inflammation
IS  - 1-2, SI
VL  - 275
DO  - 10.1016/j.jneuroim.2014.08.600
SP  - 223
EP  - 224
ER  - 
@conference{
author = "Miljković, Đorđe and Petković, Filip and Blaževski, Jana and Momčilović, Miljana and Nikolovski, Neda and Stojkovic, Marija Mostarica and Spasojevic, Ivan",
year = "2014",
journal = "Journal of Neuroimmunology",
title = "Effect of ethyl pyruvate on central nervous system inflammation",
number = "1-2, SI",
volume = "275",
doi = "10.1016/j.jneuroim.2014.08.600",
pages = "223-224"
}
Miljković, Đ., Petković, F., Blaževski, J., Momčilović, M., Nikolovski, N., Stojkovic, M. M.,& Spasojevic, I.. (2014). Effect of ethyl pyruvate on central nervous system inflammation. in Journal of Neuroimmunology, 275(1-2, SI), 223-224.
https://doi.org/10.1016/j.jneuroim.2014.08.600
Miljković Đ, Petković F, Blaževski J, Momčilović M, Nikolovski N, Stojkovic MM, Spasojevic I. Effect of ethyl pyruvate on central nervous system inflammation. in Journal of Neuroimmunology. 2014;275(1-2, SI):223-224.
doi:10.1016/j.jneuroim.2014.08.600 .
Miljković, Đorđe, Petković, Filip, Blaževski, Jana, Momčilović, Miljana, Nikolovski, Neda, Stojkovic, Marija Mostarica, Spasojevic, Ivan, "Effect of ethyl pyruvate on central nervous system inflammation" in Journal of Neuroimmunology, 275, no. 1-2, SI (2014):223-224,
https://doi.org/10.1016/j.jneuroim.2014.08.600 . .